MAR-Cetirizine 20 mg tablet: Out of specification (Impurities)
Brand(s)
Last updated
Summary
Product
MAR-Cetirizine 20 mg tablet
Issue
Health products - Product quality
What to do
Consult your health care professional if you have any health concerns.
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot numbers |
|---|---|---|---|---|---|
Marcan Pharmaceuticals |
MAR-Cetirizine 20 mg tablet |
DIN 02427141 |
Tablet |
Cetirizine hydrochloride 20 mg |
H221345 |
Issue
The impurities are out of specification in the affected lot.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Related recalls and alerts
Additional information
Background
Depth of recall: Retailers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
Marcan Pharmaceuticals Inc.
2 Gurdwara Road, Suite # 112,
Ottawa, Ontario K2E 1A2
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type II
Identification number
RA-77145
Get notified
Receive notifications for new and updated recalls and alerts by category.